Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

BACKGROUND: Adult-onset Still’s disease (AOSD) is a rare inflammatory condition characterized by fever, rash, and arthritis. Because of its rarity, clinical trials are inherently small and often uncontrolled. Our objective was to develop recommendations for the use of interleukin (IL)-1 inhibitors i...

Descripción completa

Detalles Bibliográficos
Autores principales: Colafrancesco, Serena, Manara, Maria, Bortoluzzi, Alessandra, Serban, Teodora, Bianchi, Gerolamo, Cantarini, Luca, Ciccia, Francesco, Dagna, Lorenzo, Govoni, Marcello, Montecucco, Carlomaurizio, Priori, Roberta, Ravelli, Angelo, Sfriso, Paolo, Sinigaglia, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907145/
https://www.ncbi.nlm.nih.gov/pubmed/31829244
http://dx.doi.org/10.1186/s13075-019-2021-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907145/
https://www.ncbi.nlm.nih.gov/pubmed/31829244
http://dx.doi.org/10.1186/s13075-019-2021-9

Ejemplares similares